A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE
Clinical trial NCT03312907 · COMPLETED
Trial details
- NCT number
- NCT03312907
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2020-05-29
- Enrollment
- 292
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.